FOXP3 and type 2 diabetes mellitus: A systematic review and meta-analysis reported a significant reduction in peripheral CD4+Foxp3+ Tregs in patients living with T2D compared to healthy controls, with even greater reductions observed in those with diabetes-related complications (9).